NYSEAMERICAN:XTNT - Xtant Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.02 0.00 (0.00 %)
(As of 03/24/2019 06:55 AM ET)
Previous Close$3.0199
Today's Range$2.80 - $3.0784
52-Week Range$1.61 - $8.89
Volume19,185 shs
Average Volume13,453 shs
Market Capitalization$39.78 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

Receive XTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for XTNT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNYSEAMERICAN:XTNT
CUSIPN/A
Phone+1-406-3880480

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$39.78 million
Next Earnings Date3/27/2019 (Estimated)
OptionableNot Optionable

Xtant Medical (NYSEAMERICAN:XTNT) Frequently Asked Questions

What is Xtant Medical's stock symbol?

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

When did Xtant Medical's stock split? How did Xtant Medical's stock split work?

Xtant Medical shares reverse split on Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of Xtant Medical stock prior to the reverse split would have 8 shares after the split.

How were Xtant Medical's earnings last quarter?

Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) posted its quarterly earnings data on Tuesday, August, 7th. The medical device company reported ($0.38) earnings per share for the quarter, missing the consensus estimate of ($0.26) by $0.12. The medical device company earned $18.74 million during the quarter. View Xtant Medical's Earnings History.

When is Xtant Medical's next earnings date?

Xtant Medical is scheduled to release their next quarterly earnings announcement on Wednesday, March 27th 2019. View Earnings Estimates for Xtant Medical.

What price target have analysts set for XTNT?

1 Wall Street analysts have issued twelve-month price targets for Xtant Medical's stock. Their forecasts range from $6.00 to $6.00. On average, they anticipate Xtant Medical's share price to reach $6.00 in the next year. This suggests a possible upside of 98.7% from the stock's current price. View Analyst Price Targets for Xtant Medical.

What is the consensus analysts' recommendation for Xtant Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Xtant Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Xtant Medical.

Has Xtant Medical been receiving favorable news coverage?

News headlines about XTNT stock have trended positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Xtant Medical earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned news coverage about the medical device company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the immediate future.

What other stocks do shareholders of Xtant Medical own?

Who are Xtant Medical's key executives?

Xtant Medical's management team includes the folowing people:
  • Carl D. O'Connell, President, Chief Executive Officer (Age 53)
  • Darrel Lee Holmes, Chief Operating Officer (Age 62)
  • Gregory Juda Ph.D., Chief Scientific Officer (Age 39)
  • John K. Bakewell, Director (Age 55)
  • Michael Eggenberg, Director
  • Michael R. Mainelli Jr., Director (Age 55)
  • Robert E. McNamara, Director (Age 61)
  • Jeffrey J. Peters, Director

Who are Xtant Medical's major shareholders?

Xtant Medical's stock is owned by many different of institutional and retail investors. Top institutional investors include Telemetry Investments L.L.C. (6.05%). View Institutional Ownership Trends for Xtant Medical.

Which institutional investors are buying Xtant Medical stock?

XTNT stock was acquired by a variety of institutional investors in the last quarter, including Telemetry Investments L.L.C.. View Insider Buying and Selling for Xtant Medical.

How do I buy shares of Xtant Medical?

Shares of XTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Xtant Medical's stock price today?

One share of XTNT stock can currently be purchased for approximately $3.0199.

How big of a company is Xtant Medical?

Xtant Medical has a market capitalization of $39.78 million.

What is Xtant Medical's official website?

The official website for Xtant Medical is http://xtantmedical.com/.

How can I contact Xtant Medical?

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The medical device company can be reached via phone at +1-406-3880480.


MarketBeat Community Rating for Xtant Medical (NYSEAMERICAN XTNT)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  80 (Vote Outperform)
Underperform Votes:  50 (Vote Underperform)
Total Votes:  130
MarketBeat's community ratings are surveys of what our community members think about Xtant Medical and other stocks. Vote "Outperform" if you believe XTNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XTNT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/24/2019 by MarketBeat.com Staff

Featured Article: Trading Ex-Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel